The role of metal regulatory proteins in brain oxidative stress: A tutorial

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Briner, Wayne ^a  

^a UNIVERSITY OF NEBRASKA AT KEARNEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PROCESS; DISEASE PROCESS; PHYSIOLOGICAL PROCESS; REDOX ACTIVITY; REGULATORY PROTEIN;

METABOLISM; METALS; PHYSIOLOGY; REDOX REACTIONS;

PROTEINS;

ALBUMIN; AMYLOID PRECURSOR PROTEIN; ATOX 1 PROTEIN; ATX 1 PROTEIN; CALCIUM; CARRIER PROTEIN; CATALASE; CATION; CERULOPLASMIN; COPPER CHAPERONE PEPTIDE; COPPER TRANSPORT ATPASE; COPPER TRANSPORTER 1; FERRITIN; GLUTATHIONE; HEPCIDIN; ION CHANNEL; MATRIX METALLOPROTEINASE; METALLOTHIONEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; REGULATOR PROTEIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; METAL; PROTEIN;

COPPER METABOLISM; DRUG TARGETING; HUMAN; IRON METABOLISM; METAL METABOLISM; NONHUMAN; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN ANALYSIS; REGULATORY MECHANISM; REVIEW; ANIMAL; BRAIN; METABOLISM; PATHOLOGY;

ANIMALS; BRAIN; HUMANS; METALS; OXIDATIVE STRESS; PROTEINS;

MLCS; MLOWN;

EID: 84871831588     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/981561     Document Type: Review

References (50)

1. Oettl K., Stauber R. E., Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. British Journal of Pharmacology 2007 151 5 580 590 2-s2.0-34347324020 10.1038/sj.bjp.0707251 (Pubitemid 47016287)
2. Turell L., Carballal S., Botti H., Radi R., Alvarez B., Oxidation of the albumin thiol to sulfenic acid and its implications in the intravascular compartment. Brazilian Journal of Medical and Biological Research 2009 42 4 305 311 2-s2.0-65549092679
3. Finefrock A. E., Bush A. I., Doraiswamy P. M., Current status of metals as therapeutic targets in Alzheimer's disease. Journal of the American Geriatrics Society 2003 51 8 1143 1148 2-s2.0-0042021925 10.1046/j.1532-5415. 2003.51368.x (Pubitemid 36993474)
4. Maynard C. J., Bush A. I., Masters C. L., Cappai R., Li Q.-X., Metals and amyloid- β in Alzheimer's disease. International Journal of Experimental Pathology 2005 86 3 147 159 2-s2.0-20444440369 10.1111/j.0959-9673.2005.00434.x (Pubitemid 40813911)
5. Zheng H., Koo E. H., Biology and pathophysiology of the amyloid precursor protein. Molecular Neurodegeneration 2011 6 1, article 27 2-s2.0-79955128215 10.1186/1750-1326-6-27
6. Kuo M. T., Chen H. H. W., Song I. S., Savaraj N., Ishikawa T., The roles of copper transporters in cisplatin resistance. Cancer and Metastasis Reviews 2007 26 1 71 83 2-s2.0-33947407250 10.1007/s10555-007-9045-3 (Pubitemid 46452185)
7. Harris E. D., Copper homeostasis: the role of cellular transporters. Nutrition Reviews 2001 59 9 281 285 2-s2.0-0034832606 (Pubitemid 32879067)
8. Lutsenko S., Tsivkovskii R., Walker J. M., Functional properties of the human copper-transporting ATPase ATP7B (the Wilson's disease protein) and regulation by metallochaperone Atox1. Annals of the New York Academy of Sciences 2003 986 204 211 2-s2.0-0037903315 (Pubitemid 36584083)
9. Moore S. D. P., Helmle K. E., Prat L. M., Cox D. W., Tissue localization of the copper chaperone ATOX1 and its potential role in disease. Mammalian Genome 2002 13 10 563 568 2-s2.0-0036800925 10.1007/s00335-002-2172-9 (Pubitemid 35217508)
10. Florea A.-M., Büsselberg D., Anti-cancer drugs interfere with intracellular calcium signaling. NeuroToxicology 2009 30 5 803 810 2-s2.0-70349728402 10.1016/j.neuro.2009.04.014
11. Simms B. A., Zamponi G. W., Trafficking and stability of voltage-gated calcium channels. Cellular and Molecular Life Sciences 2012 69 6 843 856
12. 3+ competes with permeant ions for the selectivity filter. Biochimica et Biophysica Acta 2010 1798 11 2013 2021 2-s2.0-77956071277 10.1016/j.bbamem.2010.08.001
13. Paradis M., Gagné J., Mateescu M. A., Paquin J., The effects of nitric oxide-oxidase and putative glutathione-peroxidase activities of ceruloplasmin on the viability of cardiomyocytes exposed to hydrogen peroxide. Free Radical Biology and Medicine 2010 49 12 2019 2027 2-s2.0-78650169776 10.1016/j.freeradbiomed.2010.09.030
14. Shukla N., Maher J., Masters J., Angelini G. D., Jeremy J. Y., Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor? Atherosclerosis 2006 187 2 238 250 2-s2.0-33646186045 10.1016/j.atherosclerosis.2005.11.035 (Pubitemid 43963031)
15. Golden T. R., Patel M., Catalytic antioxidants and neurodegeneration. Antioxidants and Redox Signaling 2009 11 3 555 569 2-s2.0-58849132856 10.1089/ars.2008.2256
16. Eisses J. F., Kaplan J. H., The mechanism of copper uptake mediated by human CTR1: a mutational analysis. Journal of Biological Chemistry 2005 280 44 37159 37168 2-s2.0-27744526783 10.1074/jbc.M508822200 (Pubitemid 41587800)
17. Lee J., Prohaska J. R., Thiele D. J., Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development. Proceedings of the National Academy of Sciences of the United States of America 2001 98 12 6842 6847 2-s2.0-0035811053 10.1073/pnas.111058698 (Pubitemid 32538304)
18. Nose Y., Kim B. E., Thiele D. J., Ctr1 drives intestinal copper absorption and is essential for growth, iron metabolism, and neonatal cardiac function. Cell Metabolism 2006 4 3 235 244 2-s2.0-33747849534 10.1016/j.cmet.2006.08.009 (Pubitemid 44283961)
19. Sharp P. A., Ctr1 and its role in body copper homeostasis. International Journal of Biochemistry and Cell Biology 2003 35 3 288 291 2-s2.0-0037345359 10.1016/S1357-2725(02)00134-6 (Pubitemid 36084449)
20. Harris E. D., Cellular copper transport and metabolism. Annual Review of Nutrition 2000 20 291 310 2-s2.0-0033826437 10.1146/annurev.nutr.20.1.291
21. La Fontaine S., Mercer J. F. B., Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis. Archives of Biochemistry and Biophysics 2007 463 2 149 167 2-s2.0-34447103789 10.1016/j.abb.2007.04.021 (Pubitemid 47030343)
22. Prohaska J. R., Gybina A. A., Intracellular copper transport in mammals. Journal of Nutrition 2004 134 5 1003 1006 2-s2.0-2442471606 (Pubitemid 38619931)
23. Solioz M., Copper pumping ATPases: common concepts in bacteria and man. FEBS Letters 1994 346 1 44 47 2-s2.0-0028233790 10.1016/0014-5793(94)00316-5 (Pubitemid 24183825)
24. Andrews N. C., Metal transporters and disease. Current Opinion in Chemical Biology 2002 6 2 181 186 2-s2.0-0036525721 10.1016/S1367-5931(02)00307- 1 (Pubitemid 34251373)
25. Mims M. P., Prchal J. T., Divalent metal transporter 1. Hematology 2005 10 4 339 345 2-s2.0-29144450958 10.1080/10245330500093419 (Pubitemid 41801131)
26. Moos T., Morgan E. H., The metabolism of neuronal iron and its pathogenic role in neurological disease review. Annals of the New York Academy of Sciences 2004 1012 14 26 2-s2.0-1842504357 10.1196/annals.1306.002 (Pubitemid 38453512)
27. Balla G., Jacob H. S., Balla J., Rosenberg M., Nath K., Apple F., Eaton J. W., Vercellotti G. M., Ferritin: a cytoprotective antioxidant strategem of endothelium. Journal of Biological Chemistry 1992 267 25 18148 18153 2-s2.0-0026657174
28. Cairo G., Tacchini L., Pogliaghi G., Anzon E., Tomasi A., Bernelli-Zazzera A., Induction of ferritin synthesis by oxidative stress. Transcriptional and post-transcriptional regulation by expansion of the "free" iron pool. Journal of Biological Chemistry 1995 270 2 700 703 2-s2.0-0028928738 10.1074/jbc.270.2.700
29. Thomas C. E., Morehouse L. A., Aust S. D., Ferritin and superoxide-dependent lipid peroxidation. The Journal of Biological Chemistry 1985 260 6 3275 3280 2-s2.0-0021993608 (Pubitemid 15115239)
30. Torti F. M., Torti S. V., Regulation of ferritin genes and protein. Blood 2002 99 10 3505 3516 2-s2.0-0037093202 10.1182/blood.V99.10.3505 (Pubitemid 34534516)
31. Müller T., Kuhn W., Homocysteine levels after acute levodopa intake in patients with Parkinson's disease. Movement Disorders 2009 24 9 1339 1343 2-s2.0-69549118930 10.1002/mds.22607
32. Müller T., Muhlack S., Cysteinyl-glycine reduction as marker for levodopa-induced oxidative stress in Parkinson's disease patients. Movement Disorders 2011 26 3 543 546 2-s2.0-79953271910 10.1002/mds.23384
33. Muller T., Muhlack S., Cysteine decrease following acute levodopa intake in patients with Parkinson's disease. Neuroscience Letters 2012 521 37 39
34. Dringen R., Gutterer J. M., Hirrlinger J., Glutathione metabolism in brain: metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. European Journal of Biochemistry 2000 267 16 4912 4916 2-s2.0-0033899176 10.1046/j.1432-1327.2000.01597.x (Pubitemid 30641287)
35. Dringen R., Hirrlinger J., Glutathione pathways in the brain. Biological Chemistry 2003 384 4 505 516 2-s2.0-0038636003 10.1515/BC.2003.059 (Pubitemid 36609167)
36. Martin H. L., Teismann P., Glutathione-a review on its role and significance in Parkinson's disease. FASEB Journal 2009 23 10 3263 3272 2-s2.0-70349681975 10.1096/fj.08-125443
37. Schulz J. B., Lindenau J., Seyfried J., Dichgans J., Glutathione, oxidative stress and neurodegeneration. European Journal of Biochemistry 2000 267 16 4904 4911 2-s2.0-0033899208 10.1046/j.1432-1327.2000.01595.x (Pubitemid 30641286)
38. Kemna E. H. J. M., Tjalsma H., Willems H. L., Swinkels D. W., Hepcidin: from discovery to differential diagnosis. Haematologica 2008 93 1 90 97 2-s2.0-38549136843 10.3324/haematol.11705 (Pubitemid 351156156)
39. Nemeth E., Valore E. V., Territo M., Schiller G., Lichtenstein A., Ganz T., Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003 101 7 2461 2463 2-s2.0-0038662619 10.1182/blood-2002-10-3235 (Pubitemid 36857598)
40. Ganz T., Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003 102 3 783 788 2-s2.0-0041672570 10.1182/blood-2003-03-0672 (Pubitemid 36917762)
41. Amǎlinei C., Cǎruntu I D., Giuşcǎ S. E., Bǎlan R. A., Matrix metalloproteinases involvement in pathologic conditions. Romanian Journal of Morphology and Embryology 2010 51 2 215 228
42. Bell R. D., Zlokovic B. V., Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathologica 2009 118 1 103 113 2-s2.0-67349142021 10.1007/s00401-009-0522-3
43. Chao C., Ghorpade A., Production and roles of glial tissue inhibitor of metalloproteinases-1 in human immunodeficiency virus-1-associated dementia neuroinflammation: a review. American Journal of Infectious Diseases 2009 5 4 314 320 2-s2.0-70649106971 10.3844/ajidsp.2009.314.319
44. Michaluk P., Kaczmarek L., Matrix metalloproteinase-9 in glutamate-dependent adult brain function and dysfunction. Cell Death and Differentiation 2007 14 7 1255 1258 2-s2.0-34250727898 10.1038/sj.cdd.4402141 (Pubitemid 46969864)
45. Hao Y., Ren J., Liu J., The protective role of zinc against acute toxicity of depleted uranium in rats. Basic & Clinical Pharmacology & Toxicology 2012 111 6 402 410 10.1111/j.1742-7843.2012.00910.x
46. West A. K., Hidalgo J., Eddins D., Levin E. D., Aschner M., Metallothionein in the central nervous system: roles in protection, regeneration and cognition. Neurotoxicology 2008 29 3 489 503 2-s2.0-49949090483 10.1016/j.neuro.2007.12.006
47. Chan P. H., Reactive oxygen radicals in signaling and damage in the ischemic brain. Journal of Cerebral Blood Flow and Metabolism 2001 21 1 2 14 2-s2.0-0035149749 (Pubitemid 32036708)
48. Maritim A. C., Sanders R. A., Watkins J. B., Diabetes, oxidative stress, and antioxidants: a review. Journal of Biochemical and Molecular Toxicology 2003 17 1 24 38 2-s2.0-0037253073 10.1002/jbt.10058 (Pubitemid 36410972)
49. Tsay H.-J., Wang P., Wang S.-L., Ku H.-H., Age-associated changes of superoxide dismutase and catalase activities in the rat brain. Journal of Biomedical Science 2000 7 6 466 474 2-s2.0-0033772773
50. Xiong Y., Shie F. S., Zhang J., Lee C. P., Ho Y. S., Prevention of mitochondrial dysfunction in post-traumatic mouse brain by superoxide dismutase. Journal of Neurochemistry 2005 95 3 732 744 2-s2.0-27644509638 10.1111/j.1471-4159.2005.03412.x (Pubitemid 41567166)